April 2025

Coverage from the Tampa Regional session of the Institute for Value-Based Medicine.

Coverage from the San Francisco Regional session of the Institute for Value-Based Medicine.

Coverage from the Atlanta Regional meeting of the Institute for Value-Based Medicine.

Coverage from the Nashville Regional meeting of the Institute for Value-Based Medicine.

This article appears in the April issue of Evidence-Based Oncology.

Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.

Health care institutions with large numbers of Medicare and Medicaid patients may be constrained from offering cancer therapies made available under the accelerated approval pathway.

Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from the 2021 FDA approval of aducanumab (Aduhelm) and use of the accelerated approval pathway.